The Effect of Donepezil on Arousal Threshold and Apnea-Hypopnea Index A Randomized, Double-Blind, Cross-Over Study
dc.citation.issue | 11 | |
dc.citation.volume | 13 | |
dc.contributor.author | Li, Yanru | |
dc.contributor.author | Owens, Robert L. | |
dc.contributor.author | Sands, Scott | |
dc.contributor.author | Orr, Jeremy | |
dc.contributor.author | Moraes, Walter [UNIFESP] | |
dc.contributor.author | DeYoung, Pamela | |
dc.contributor.author | Smales, Erik | |
dc.contributor.author | Jen, Rachel | |
dc.contributor.author | Malhotra, Atul | |
dc.coverage | New York | |
dc.date.accessioned | 2020-07-31T12:47:31Z | |
dc.date.available | 2020-07-31T12:47:31Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Rationale: Obstructive sleep apnea (OSA) has multiple pathophysiological causes. A low respiratory arousal threshold (ArTh) and a high loop gain (unstable ventilatory control) can contribute to recurrent respiratory events in patients with OSA. Prior studies have shown that donepezil, an acetylcholinesterase inhibitor, might improve OSA, but the mechanism is unknown. Objectives: To determine whether a single dose of donepezil lowers the apnea-hypopnea index by modulating the ArTh or loop gain. Methods: In this randomized, double-blind, crossover trial, 41 subjects with OSA underwent two polysomnograms with ArTh and loop gain evaluated, during which 10 mg of donepezil or placebo was administered. Measurements and Main Results: Compared with placebo, sleep efficiency (77.2 vs. 71.9% | en |
dc.description.abstract | P = 0.015) and total sleep time decreased with donepezil (372 vs. 351 min | en |
dc.description.abstract | P = 0.004). No differences were found in apnea-hypopnea index (51.8 vs. 50.0 events/h | en |
dc.description.abstract | P = 0.576) or nadir oxygen saturation as determined by pulse oximetry (80.3 vs. 81.1% | en |
dc.description.abstract | P = 0.241) between placebo and donepezil, respectively. ArTh was not significantly changed (-18.9 vs. -18.0 cm H2O | en |
dc.description.abstract | P = 0.394) with donepezil. As a whole group, loop gain (ventilatory response to a 1-cycle/min disturbance) did not change significantly (P = 0.089). Conclusions: A single dose of donepezil did not appear to affect the overall severity of OSA in this patient group, and no consistent effects on ArTh or loop gain were observed. Donepezil may have minor effects on sleep architecture. | en |
dc.description.affiliation | Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China | |
dc.description.affiliation | Univ Calif San Diego, Div Pulm & Crit Care Med, 9300 Campus Point Dr,7381, La Jolla, CA 92093 USA | |
dc.description.affiliation | Brigham & Womens Hosp, Div Sleep Med, Boston, MA USA | |
dc.description.affiliation | Harvard Med Sch, Boston, MA USA | |
dc.description.affiliation | Immunol & Resp Med & Cent Clin Sch, Dept Allergy, Alfred, NY USA | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil | |
dc.description.affiliation | Univ British Columbia, Div Resp Med, Vancouver, BC, Canada | |
dc.description.affiliationUnifesp | Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | National Institutes of Health (NIH) | |
dc.description.sponsorship | National Natural Science Foundation of China | |
dc.description.sponsorship | National Health and Medical Research Council of Australia Early Career Fellowship | |
dc.description.sponsorship | R.G. Menzies award | |
dc.description.sponsorship | American Heart Association | |
dc.description.sponsorshipID | NIH: RO1 HL085188 | |
dc.description.sponsorshipID | NIH: K24 HL132105 | |
dc.description.sponsorshipID | NIH: R21 HL121794 | |
dc.description.sponsorshipID | NIH: RO1 HL 119201 | |
dc.description.sponsorshipID | NIH: RO1 HL081823 | |
dc.description.sponsorshipID | National Natural Science Foundation of China: 81200735 | |
dc.description.sponsorshipID | National Health and Medical Research Council of Australia Early Career Fellowship: 1053201 | |
dc.description.sponsorshipID | American Heart Association: 15SDG25890059 | |
dc.format.extent | 2012-2018 | |
dc.identifier | http://dx.doi.org/10.1513/AnnalsATS.201605-384OC | |
dc.identifier.citation | Annals Of The American Thoracic Society. New York, v. 13, n. 11, p. 2012-2018, 2016. | |
dc.identifier.doi | 10.1513/AnnalsATS.201605-384OC | |
dc.identifier.issn | 1546-3222 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/56876 | |
dc.identifier.wos | WOS:000419097900023 | |
dc.language.iso | eng | |
dc.publisher | Amer Thoracic Soc | |
dc.relation.ispartof | Annals Of The American Thoracic Society | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | obstructive sleep apnea | en |
dc.subject | donepezil | en |
dc.subject | arousal threshold | en |
dc.subject | loop gain | en |
dc.subject | treatment | en |
dc.title | The Effect of Donepezil on Arousal Threshold and Apnea-Hypopnea Index A Randomized, Double-Blind, Cross-Over Study | en |
dc.type | info:eu-repo/semantics/article |